Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BIJUVA | Mayne Group | N-210132 RX | 2018-10-28 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ESTROGEL | Ascend Therapeutics | N-021166 RX | 2004-02-09 | 1 products, RLD, RS |
CLIMARA | Bayer | N-020375 RX | 1994-12-22 | 6 products, RLD, RS |
MENOSTAR | Bayer | N-021674 RX | 2004-06-08 | 1 products, RLD, RS |
IMVEXXY | Mayne Group | N-208564 RX | 2018-05-29 | 2 products, RLD, RS |
MINIVELLE | Noven Pharmaceuticals | N-203752 RX | 2012-10-29 | 5 products, RLD, RS |
VAGIFEM | Novo Nordisk | N-020908 RX | 2009-11-25 | 1 products, RLD, RS |
EVAMIST | Padagis | N-022014 RX | 2007-07-27 | 1 products, RLD, RS |
ESTRING | Pfizer | N-020472 RX | 1996-04-26 | 1 products, RLD, RS |
VIVELLE-DOT | Sandoz | N-020538 RX | 1999-01-08 | 5 products, RLD, RS |
DIVIGEL | Vertical Pharmaceuticals | N-022038 RX | 2007-06-04 | 5 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACTIVELLA | Amneal Pharmaceuticals | N-020907 RX | 1998-11-18 | 1 products, RLD, RS |
COMBIPATCH | Noven Pharmaceuticals | N-020870 RX | 1998-08-07 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FEMRING | Millicent Pharma | N-021367 RX | 2003-03-20 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MYFEMBREE | Myovant Sciences | N-214846 RX | 2021-05-26 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DEPO-TESTADIOL | Pharmacia & Upjohn | N-017968 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LUNELLE | Pharmacia & Upjohn | N-020874 DISCN | 2000-10-05 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
abigale abigale lo | ANDA | 2024-09-17 |
activella | New Drug Application | 2023-11-30 |
afirmelle | ANDA | 2024-09-19 |
altavera | ANDA | 2023-03-02 |
alyacen 1/35 | ANDA | 2024-05-07 |
alyacen 1/35 alyacen 7/7/7 | ANDA | 2017-09-08 |
alyacen 7/7/7 | ANDA | 2023-06-07 |
amethia | ANDA | 2024-03-01 |
amethyst | ANDA | 2022-01-31 |
angeliq | New Drug Application | 2023-12-08 |
Expiration | Code | ||
---|---|---|---|
ESTRADIOL / NORETHINDRONE ACETATE / RELUGOLIX, MYFEMBREE, MYOVANT SCIENCES | |||
2026-01-27 | M-289 | ||
2025-12-18 | NCE | ||
2025-08-05 | I-898 | ||
2024-05-26 | NP | ||
ESTRADIOL, ESTRADIOL, CHEMO RESEARCH SL | |||
2023-04-08 | CGT |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Estradiol / Norethindrone Acetate / Relugolix, Myfembree, Myovant Sciences | |||
11033551 | 2037-09-29 | U-3129 | |
9346822 | 2024-02-17 | U-3129 | |
7300935 | 2024-01-28 | DP | |
8058280 | 2024-01-28 | DP | |
Estradiol, Imvexxy, Mayne Pharma | |||
11266661 | 2034-02-02 | U-2316, U-2317 | |
9180091 | 2033-12-20 | DP | U-2316, U-2317 |
10258630 | 2033-12-20 | U-2316, U-2317 | |
10398708 | 2033-12-20 | U-2317, U-2614 | |
10471072 | 2033-06-18 | U-2316, U-2317 | |
10568891 | 2033-06-18 | U-2316, U-2317 | |
10668082 | 2033-06-18 | U-2316, U-2317 | |
10888516 | 2033-06-18 | U-2316, U-2317 | |
11065197 | 2033-06-18 | DP | |
11116717 | 2033-06-18 | DP | |
11123283 | 2033-06-18 | DP | |
9289382 | 2032-11-21 | DP | |
10537581 | 2032-11-21 | DP | U-2316, U-2317 |
10806697 | 2032-11-21 | DP | |
10835487 | 2032-11-21 | U-2316, U-2317 | |
11241445 | 2032-11-21 | U-2316, U-2317 | |
11246875 | 2032-11-21 | U-2316, U-2317 | |
11304959 | 2032-11-21 | DP | |
11351182 | 2032-11-21 | U-2316, U-2317 | |
11497709 | 2032-11-21 | U-2316, U-2317 | |
Estradiol / Progesterone, Bijuva, Mayne Pharma | |||
8633178 | 2032-11-21 | DP | |
8846648 | 2032-11-21 | U-2439 | |
8846649 | 2032-11-21 | DP | U-2439 |
8933059 | 2032-11-21 | DP | U-2439 |
8987237 | 2032-11-21 | DP | |
8993548 | 2032-11-21 | DP | |
8993549 | 2032-11-21 | DP | |
9006222 | 2032-11-21 | DP | U-2439 |
9114145 | 2032-11-21 | U-2439 | |
9114146 | 2032-11-21 | DP | U-2439 |
9301920 | 2032-11-21 | DP | U-2439 |
10052386 | 2032-11-21 | DP | |
10206932 | 2032-11-21 | U-2439 | |
10639375 | 2032-11-21 | DP | |
10675288 | 2032-11-21 | U-2439 | |
10806740 | 2032-11-21 | DP | U-2439 |
11033626 | 2032-11-21 | DP | U-2439 |
11103513 | 2032-11-21 | U-2439 | |
11103516 | 2032-11-21 | DP | |
11110099 | 2032-11-21 | DP | |
11166963 | 2032-11-21 | DP | |
11529360 | 2032-11-21 | DP | |
Drospirenone / Estradiol, Angeliq, Bayer Hlthcare | |||
8906890 | 2031-10-22 | DP | |
Estradiol, Minivelle, Noven | |||
8231906 | 2030-07-04 | DS, DP | |
9724310 | 2028-07-10 | DS, DP | |
9730900 | 2028-07-10 | U-2086 | |
9833419 | 2028-07-10 | DP | |
Dienogest / Estradiol Valerate, Natazia, Bayer Hlthcare | |||
8153616 | 2028-01-30 | U-1240 | |
8071577 | 2026-05-13 | DP | U-1 |
Estradiol Acetate, Femtrace, Apil | |||
7572779 | 2025-10-02 | U-904 |
Code | Description |
---|---|
A9591 | Fluoroestradiol f 18, diagnostic, 1 millicurie |
J1000 | Injection, depo-estradiol cypionate, up to 5 mg |
J1380 | Injection, estradiol valerate, up to 10 mg |
J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each |
J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infertility | D007246 | EFO_0000545 | — | 15 | 16 | 15 | 34 | 68 | 143 |
Healthy volunteers/patients | — | — | — | 114 | 7 | 6 | 6 | 5 | 134 |
Contraception | D003267 | — | — | 18 | 19 | 46 | 20 | 26 | 126 |
Menopause | D008593 | EFO_0003922 | N95 | 13 | 11 | 14 | 26 | 19 | 79 |
Syndrome | D013577 | — | — | 7 | 11 | 13 | 16 | 20 | 67 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 6 | 3 | 8 | 15 | 23 | 55 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 25 | 6 | 2 | 15 | 51 |
Endometriosis | D004715 | EFO_0001065 | N80 | 2 | 10 | 16 | 11 | 8 | 43 |
Female infertility | D007247 | EFO_0008560 | N97 | 9 | 4 | 5 | 5 | 20 | 41 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 7 | 12 | 4 | 13 | 36 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myofibroma | D047708 | — | — | — | 2 | 11 | — | 4 | 17 |
Prostatic neoplasms | D011471 | — | C61 | — | 8 | 4 | — | — | 11 |
Neoplasms | D009369 | — | C80 | 5 | 3 | 1 | — | 2 | 10 |
Anorexia | D000855 | — | R63.0 | 2 | 6 | 3 | — | — | 9 |
Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | 2 | 6 | 3 | — | — | 9 |
Inflammation | D007249 | MP_0001845 | — | — | 3 | 2 | — | 3 | 8 |
Pituitary diseases | D010900 | — | E23.7 | — | 1 | 3 | — | 5 | 8 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | 3 | 2 | — | — | 6 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | 1 | — | 4 | 5 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 4 | — | 1 | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tissue adhesions | D000267 | — | — | 3 | 1 | — | — | 11 | 14 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 10 | 1 | — | — | 1 | 11 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 8 | 1 | — | — | — | 8 |
Covid-19 | D000086382 | — | U07.1 | — | 4 | — | — | 4 | 8 |
Male breast neoplasms | D018567 | — | — | 1 | 2 | — | — | 1 | 3 |
Carcinoma | D002277 | — | C80.0 | — | 3 | — | — | — | 3 |
Vulvodynia | D056650 | — | N94.81 | — | 1 | — | — | 2 | 3 |
Gender identity | D005783 | — | — | 1 | 1 | — | — | 1 | 2 |
Intracranial aneurysm | D002532 | EFO_0003870 | I67.1 | — | 1 | — | — | 1 | 2 |
Hemostasis | D006487 | — | — | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 13 | — | — | — | 1 | 14 |
Therapeutic equivalency | D013810 | — | — | 11 | — | — | — | 1 | 12 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 2 | — | — | — | 6 | 8 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 4 | — | — | — | 3 | 7 |
Drug interactions | D004347 | — | — | 6 | — | — | — | 1 | 7 |
Hepatitis c | D006526 | — | B19.2 | 7 | — | — | — | — | 7 |
Transgenes | D019076 | — | — | 1 | — | — | — | 2 | 3 |
Pain | D010146 | EFO_0003843 | R52 | 2 | — | — | — | 1 | 3 |
Asthma | D001249 | EFO_0000270 | J45 | 3 | — | — | — | — | 3 |
Long qt syndrome | D008133 | HP_0001657 | I45.81 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | — | — | — | 4 | 4 |
Thromboembolism | D013923 | — | — | — | — | — | — | 4 | 4 |
Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | — | — | 3 | 3 |
Menstrual cycle | D008597 | — | — | — | — | — | — | 3 | 3 |
Cerebrospinal fluid leak | D065634 | — | G96.0 | — | — | — | — | 3 | 3 |
Uterine cervical neoplasms | D002583 | — | — | — | — | — | — | 2 | 2 |
Traumatic brain injuries | D000070642 | — | S06 | — | — | — | — | 2 | 2 |
Disease | D004194 | EFO_0000408 | R69 | — | — | — | — | 2 | 2 |
Vascular stiffness | D059289 | — | — | — | — | — | — | 2 | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 2 | 2 |
Drug common name | Estradiol |
INN | estradiol valerate |
Description | 17beta-estradiol is the 17beta-isomer of estradiol. It has a role as an estrogen, a human metabolite, an EC 1.2.3.1 (aldehyde oxidase) inhibitor, a Daphnia magna metabolite, a mouse metabolite and a geroprotector. It is a 17beta-hydroxy steroid and an estradiol. |
Classification | Small molecule |
Drug class | estrogens |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O |
PDB | — |
CAS-ID | 50-28-2 |
RxCUI | — |
ChEMBL ID | CHEMBL135 |
ChEBI ID | 16469 |
PubChem CID | 5757 |
DrugBank | DB00783 |
UNII ID | 4TI98Z838E (ChemIDplus, GSRS) |